Targeting of insulin-like growth factor type 1 receptor in Ewing sarcoma: unfulfilled promise or a promising beginning? uri icon

Overview

publication date

  • October 24, 2011

Research

keywords

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Bone Neoplasms
  • Receptor, IGF Type 1
  • Sarcoma, Ewing

Identity

PubMed Central ID

  • PMC3675677

Scopus Document Identifier

  • 83255188851

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.38.2374

PubMed ID

  • 22025158

Additional Document Info

volume

  • 29

issue

  • 34